FI117321B - Stabiili pakastekuivattu koostumus, joka sisältää proteiinia ja testipakkaus - Google Patents
Stabiili pakastekuivattu koostumus, joka sisältää proteiinia ja testipakkaus Download PDFInfo
- Publication number
- FI117321B FI117321B FI952119A FI952119A FI117321B FI 117321 B FI117321 B FI 117321B FI 952119 A FI952119 A FI 952119A FI 952119 A FI952119 A FI 952119A FI 117321 B FI117321 B FI 117321B
- Authority
- FI
- Finland
- Prior art keywords
- freeze
- alanine
- mannitol
- protein
- dried
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9405486 | 1994-05-04 | ||
FR9405486A FR2719479B1 (fr) | 1994-05-04 | 1994-05-04 | Formulation stable lyophilisée comprenant une protéine: kit de dosage. |
Publications (3)
Publication Number | Publication Date |
---|---|
FI952119A0 FI952119A0 (fi) | 1995-05-03 |
FI952119A FI952119A (fi) | 1995-11-05 |
FI117321B true FI117321B (fi) | 2006-09-15 |
Family
ID=9462880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI952119A FI117321B (fi) | 1994-05-04 | 1995-05-03 | Stabiili pakastekuivattu koostumus, joka sisältää proteiinia ja testipakkaus |
Country Status (25)
Country | Link |
---|---|
US (1) | US5763409A (es) |
EP (1) | EP0682944B1 (es) |
JP (1) | JP2948125B2 (es) |
KR (1) | KR100273053B1 (es) |
CN (1) | CN1088583C (es) |
AT (1) | ATE178484T1 (es) |
AU (1) | AU694763B2 (es) |
CA (1) | CA2148537C (es) |
CZ (1) | CZ286195B6 (es) |
DE (1) | DE69508837T2 (es) |
DK (1) | DK0682944T3 (es) |
ES (1) | ES2131781T3 (es) |
FI (1) | FI117321B (es) |
FR (1) | FR2719479B1 (es) |
GR (1) | GR3030146T3 (es) |
HU (1) | HU220220B (es) |
IL (1) | IL113578A (es) |
MX (1) | MX9502034A (es) |
NO (1) | NO320364B1 (es) |
NZ (1) | NZ272045A (es) |
PL (1) | PL179240B1 (es) |
RU (1) | RU2136306C1 (es) |
SI (1) | SI0682944T1 (es) |
TW (1) | TW397687B (es) |
ZA (1) | ZA953596B (es) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
CN102416176A (zh) * | 1995-07-27 | 2012-04-18 | 基因技术股份有限公司 | 稳定等渗的冻干蛋白质制剂 |
US6685940B2 (en) | 1995-07-27 | 2004-02-03 | Genentech, Inc. | Protein formulation |
DE19539574A1 (de) * | 1995-10-25 | 1997-04-30 | Boehringer Mannheim Gmbh | Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren |
FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
EP0852951A1 (de) * | 1996-11-19 | 1998-07-15 | Roche Diagnostics GmbH | Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern |
FR2768341B1 (fr) * | 1997-09-18 | 2000-04-14 | Lab Francais Du Fractionnement | Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides |
EP0913177A1 (de) * | 1997-11-03 | 1999-05-06 | Roche Diagnostics GmbH | Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung |
EP0913178A1 (en) * | 1997-11-03 | 1999-05-06 | Boehringer Mannheim Gmbh | Process for the manufacture of dry, amorphous products comprising biologically active material by means of convection drying and products obtainable by the process |
EP1071465A1 (en) * | 1998-03-18 | 2001-01-31 | Ronai, Peter | Amorphous glasses for stabilising sensitive products |
EP1154796B1 (en) * | 1999-02-22 | 2007-06-20 | University of Connecticut | Novel albumin-free factor viii formulations |
IL149355A0 (en) * | 1999-10-28 | 2002-11-10 | Inst Neftechimicheskogo Sintez | Polypeptide corporation |
US6653062B1 (en) | 2000-07-26 | 2003-11-25 | Wisconsin Alumni Research Foundation | Preservation and storage medium for biological materials |
DE60139339D1 (de) | 2000-11-07 | 2009-09-03 | Novartis Vaccines & Diagnostic | Stabilisierte interferonzusammensetzungen |
US6887462B2 (en) * | 2001-04-09 | 2005-05-03 | Chiron Corporation | HSA-free formulations of interferon-beta |
AU2002350622B2 (en) * | 2001-10-24 | 2006-09-14 | Pari Pharma Gmbh | Kit for the preparation of a pharmaceutical composition |
US7309468B2 (en) | 2002-05-13 | 2007-12-18 | Becton, Dickinson And Company | Protease inhibitor sample collection system |
US6803046B2 (en) * | 2002-08-16 | 2004-10-12 | Bracco International B.V. | Sincalide formulations |
JP2008500942A (ja) * | 2003-01-08 | 2008-01-17 | カイロン コーポレイション | 組織因子経路インヒビターまたは組織因子経路インヒビター改変体を含有する安定化凍結乾燥組成物 |
GB0304636D0 (en) * | 2003-02-28 | 2003-04-02 | Britannia Pharmaceuticals Ltd | Pharmaceutical composition for nasal delivery |
DE10333317A1 (de) * | 2003-07-22 | 2005-02-17 | Biotecon Therapeutics Gmbh | Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA) |
GB0404586D0 (en) * | 2004-03-01 | 2004-04-07 | Britannia Pharmaceuticals Ltd | Improvements in or relating to organic materials |
US11229746B2 (en) | 2006-06-22 | 2022-01-25 | Excelsior Medical Corporation | Antiseptic cap |
WO2008057550A2 (en) * | 2006-11-07 | 2008-05-15 | Sanofi Pasteur Biologics Co. | Stabilization of vaccines by lyophilization |
US7951368B2 (en) * | 2007-06-25 | 2011-05-31 | Amgen Inc. | Compositions of specific binding agents to hepatocyte growth factor |
GB0715285D0 (en) * | 2007-08-06 | 2007-09-12 | Britannia Pharmaceuticals Ltd | Improvements in or relating to powdered medicaments for nasal delivery |
US9078992B2 (en) | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
BRPI0921429B1 (pt) | 2008-11-07 | 2022-07-12 | Takeda Pharmaceutical Company Limited | Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável |
RU2011126338A (ru) * | 2008-11-28 | 2013-01-10 | Эбботт Лэборетриз | Стабильные композиции антител и способы их стабилизации |
NZ599783A (en) * | 2009-11-03 | 2013-10-25 | Grifols Therapeutics Inc | Composition and use for alpha-1 proteinase inhibitor |
EP3257525A3 (en) * | 2009-12-22 | 2018-02-28 | Celldex Therapeutics, Inc. | Vaccine compositions |
RU2448156C1 (ru) * | 2011-03-17 | 2012-04-20 | Эспосито Трейдинг Лтд | Способ получения лиофилизированной субстанции |
RU2448158C1 (ru) * | 2011-03-24 | 2012-04-20 | Эспосито Трейдинг Лтд | Способ получения препарата фортелизин, обладающего фибринолитическими свойствами, и его применение для лечения инфаркта миокарда |
CA2841832C (en) | 2011-07-12 | 2019-06-04 | Pursuit Vascular, Inc. | Device for delivery of antimicrobial agent into a trans-dermal catheter |
DK2760998T3 (en) * | 2011-11-22 | 2017-04-24 | Siemens Healthcare Diagnostics Inc | Devices with dried reagents for reconstitution as calibration and / or quality control solutions, and methods of preparation and use thereof |
US20140017318A1 (en) * | 2012-07-10 | 2014-01-16 | Kevin O'Connell | Method to produce a medicinal product comprising a biologically active protein and the resulting product |
US9314519B2 (en) | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
US9393298B2 (en) | 2013-03-15 | 2016-07-19 | Intervet Inc. | Liquid stable bovine virus vaccines |
US9480739B2 (en) | 2013-03-15 | 2016-11-01 | Intervet Inc. | Bovine virus vaccines that are liquid stable |
AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
US10987425B2 (en) | 2013-09-27 | 2021-04-27 | Hanmi Pharm. Co., Ltd. | Liquid formulation of long-acting human growth hormone immunoglobulin conjugate |
AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
TWI670085B (zh) | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
US10046156B2 (en) | 2014-05-02 | 2018-08-14 | Excelsior Medical Corporation | Strip package for antiseptic cap |
JP6822978B2 (ja) | 2015-05-08 | 2021-01-27 | アイシーユー・メディカル・インコーポレーテッド | 治療薬のエミッタを受け入れるように構成された医療用コネクタ |
WO2016201202A1 (en) | 2015-06-11 | 2016-12-15 | Attwill Medical Solutions Inc. | Medical devices, systems, and methods utilizing antithrombin-heparin compositions |
PL3525865T3 (pl) | 2016-10-14 | 2023-02-06 | Icu Medical, Inc. | Nasadki dezynfekcyjne dla łączników medycznych |
WO2018204206A2 (en) | 2017-05-01 | 2018-11-08 | Icu Medical, Inc. | Medical fluid connectors and methods for providing additives in medical fluid lines |
US11110063B2 (en) | 2017-08-25 | 2021-09-07 | MAIA Pharmaceuticals, Inc. | Storage stable sincalide formulations |
US11541221B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Tubing set with antimicrobial properties |
US11541220B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Needleless connector with antimicrobial properties |
US11534595B2 (en) | 2018-11-07 | 2022-12-27 | Icu Medical, Inc. | Device for delivering an antimicrobial composition into an infusion device |
US11517732B2 (en) | 2018-11-07 | 2022-12-06 | Icu Medical, Inc. | Syringe with antimicrobial properties |
US11400195B2 (en) | 2018-11-07 | 2022-08-02 | Icu Medical, Inc. | Peritoneal dialysis transfer set with antimicrobial properties |
US11433215B2 (en) | 2018-11-21 | 2022-09-06 | Icu Medical, Inc. | Antimicrobial device comprising a cap with ring and insert |
EP4255552A1 (en) | 2020-12-07 | 2023-10-11 | ICU Medical, Inc. | Peritoneal dialysis caps, systems and methods |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5822445B2 (ja) * | 1982-07-08 | 1983-05-09 | 株式会社 ミドリ十字 | 安定な固体の人血漿コリンエステラ−ゼ製剤の製法 |
US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
JPH0296536A (ja) * | 1988-09-29 | 1990-04-09 | Green Cross Corp:The | プラスミノゲン乾燥製剤 |
DE59007142D1 (de) * | 1990-01-18 | 1994-10-20 | Cereria Amos Sgarbi Spa | Grablicht. |
US5192743A (en) * | 1992-01-16 | 1993-03-09 | Genentech, Inc. | Reconstitutable lyophilized protein formulation |
SE9201073D0 (sv) * | 1992-04-03 | 1992-04-03 | Kabi Pharmacia Ab | Protein formulation |
DE4239877C1 (de) * | 1992-11-27 | 1994-03-17 | Boehringer Ingelheim Int | Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung |
-
1994
- 1994-05-04 FR FR9405486A patent/FR2719479B1/fr not_active Expired - Lifetime
-
1995
- 1995-04-26 CZ CZ19951081A patent/CZ286195B6/cs not_active IP Right Cessation
- 1995-04-28 PL PL95308416A patent/PL179240B1/pl unknown
- 1995-04-28 JP JP7106227A patent/JP2948125B2/ja not_active Expired - Lifetime
- 1995-05-02 ES ES95401012T patent/ES2131781T3/es not_active Expired - Lifetime
- 1995-05-02 EP EP95401012A patent/EP0682944B1/fr not_active Expired - Lifetime
- 1995-05-02 AT AT95401012T patent/ATE178484T1/de active
- 1995-05-02 NZ NZ272045A patent/NZ272045A/en not_active IP Right Cessation
- 1995-05-02 DE DE69508837T patent/DE69508837T2/de not_active Expired - Lifetime
- 1995-05-02 US US08/432,839 patent/US5763409A/en not_active Expired - Lifetime
- 1995-05-02 AU AU17774/95A patent/AU694763B2/en not_active Expired
- 1995-05-02 IL IL11357895A patent/IL113578A/xx not_active IP Right Cessation
- 1995-05-02 SI SI9530241T patent/SI0682944T1/xx unknown
- 1995-05-02 DK DK95401012T patent/DK0682944T3/da active
- 1995-05-02 MX MX9502034A patent/MX9502034A/es unknown
- 1995-05-03 NO NO19951724A patent/NO320364B1/no not_active IP Right Cessation
- 1995-05-03 RU RU95107153/14A patent/RU2136306C1/ru active
- 1995-05-03 TW TW084104433A patent/TW397687B/zh not_active IP Right Cessation
- 1995-05-03 HU HU9501276A patent/HU220220B/hu unknown
- 1995-05-03 FI FI952119A patent/FI117321B/fi not_active IP Right Cessation
- 1995-05-03 CA CA002148537A patent/CA2148537C/en not_active Expired - Lifetime
- 1995-05-04 CN CN95104797A patent/CN1088583C/zh not_active Expired - Lifetime
- 1995-05-04 ZA ZA953596A patent/ZA953596B/xx unknown
- 1995-05-04 KR KR1019950011157A patent/KR100273053B1/ko not_active IP Right Cessation
-
1999
- 1999-05-06 GR GR990401232T patent/GR3030146T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI117321B (fi) | Stabiili pakastekuivattu koostumus, joka sisältää proteiinia ja testipakkaus | |
EP0857060B1 (de) | Zubereitungen und verfahren zur stabilisierung biologischer materialien mittels trocknungsverfahren ohne einfrieren | |
EP0721343B1 (en) | Pharmaceutical formulations of nerve growth factor | |
KR100700869B1 (ko) | Pth, 완충제 및 안정제를 포함하는 안정한 pth조성물 | |
KR101880905B1 (ko) | 안정한 수성 mia/cd-rap 제제 | |
KR20160105443A (ko) | 뉴레귤린 제제의 처방 | |
NZ550200A (en) | A method of lysing a blood clot comprising administering a fibrinolytic agent selected from fibrolase and NAT to a non-human animal | |
US7449444B2 (en) | Hydroxyethyl starch-containing polypeptide compositions | |
AU659997B2 (en) | Stable pharmaceutical compositions containing a fibroblast growth factor | |
US6152897A (en) | Syringe | |
AU2006200638B2 (en) | Pharmaceutical compositions of fibrinolytic agent | |
KR0133998B1 (ko) | 위장질환 치료용 의약 조성물 | |
KR20050079740A (ko) | 산안정성 단백질의 주사용 용액 제형 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: SANOFI-AVENTIS |
|
FG | Patent granted |
Ref document number: 117321 Country of ref document: FI |
|
MA | Patent expired |